Kathleen Tregoning, See Remarks at Cerevel Therapeutics Holdings, Inc. (CERE), sold 12,576 shares at $41.42 ($521K) on 2023-12-20, disclosed to the SEC on 2023-12-21.
Open-market sale of $521k CERE by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.42 | 6,288 | $260K | 50.0% |
| 2 | $41.42 | 6,288 | $260K | 50.0% |
| Total | $41.42 avg | 12,576 | $521K | 100% |